Tag Archives: FDA

State Attorneys General March 20 Update

Squire Patton Boggs’ State Attorneys General Practice Group is comprised of lawyers who have served at senior levels in state AG offices around the country and whose practices focus, to one degree or another, on representing clients before these increasingly assertive and powerful, yet often overlooked, government agencies, as explained in detail here. In these … Continue Reading

State Attorneys General January 9 Update

Squire Patton Boggs’ State Attorneys General Practice Group is comprised of lawyers who have served at senior levels in state AG offices around the country and whose practices focus, to one degree or another, on representing clients before these increasingly assertive and powerful, yet often overlooked, government agencies, as explained in detail here. In these … Continue Reading

USDA’s Catfish Inspection Program Revisited

Legislative Activity Catfish Inspection Program Although discussions surrounding government regulation of catfish have slowed on Capitol Hill since the enactment of the 2014 Farm Bill, the catfish inspection program at the United States Department of Agriculture (USDA) is likely to once again be the subject of great scrutiny and debate as legislators begin to prepare … Continue Reading

Two Health Bills Scheduled for House Floor; Senate to Consider Opioid Abuse Legislation; CMS Releases Proposed Rule on Provider Integrity; MedPAC Meets This Week

Legislative Activity Two Health Bills Scheduled for House Floor House Majority Leader Kevin McCarthy (R-CA) has stated that the chamber may consider two health bills this coming week. On Tuesday, March 1, the House is expected to consider H.R. 2814, to Name the Department of Veterans Affairs Community-Base Outpatient Clinic in Sevierville, Tennessee, the Dannie … Continue Reading

Senate Cloture Vote Scheduled for FDA Nominee, Chamber May Consider Opioid Legislation

Legislative Activity Senate Cloture Vote Scheduled for FDA Nominee, Chamber May Consider Opioid Legislation On Monday, February 22, Senate Majority Leader Mitch McConnell (R-KY) has scheduled a cloture vote on the nomination of Dr. Robert Califf for Food and Drug Administration (FDA) Commissioner.   Three Senators – Joe Manchin (D-WV), Ed Markey (D-MA), and Bernie Sanders … Continue Reading

Congress Awaits Health Provisions in President’s Budget; Health Bills Slated for House Floor Consideration; SAMHSA Releases Proposed Rule Focused on Confidentiality of Substance Use Disorder Patient Records

Legislative Activity Congress Awaits Health Provisions in President’s Budget On Tuesday, February 9, President Barack Obama will submit his FY 2017 Budget Request to Congress, which is expected to include several large-scale investments for the nation’s health. Last week, the White House released a “sneak preview” of the Budget, which includes: $755 million for cancer … Continue Reading

President May Highlight Obamacare Successes in State of the Union Address; HHS-OCR Releases HIPAA Guidance; MedPAC Meeting This Week

Legislative Activity President May Highlight Obamacare Successes in State of the Union Address On Tuesday, January 12, President Barack Obama will give his final State of the Union address to Congress. While details of the speech have yet to be released, last week, the President vetoed Congress’s budget reconciliation bill, which aimed to dismantle the … Continue Reading

Lawmakers To Vie For House Ways And Means Gavel; FDA Names Medical Device Security As A Priority; CMS Releases Proposed Notice On Basic Health Program Funding

Legislative Activity Lawmakers To Vie For House Ways And Means Gavel With Rep. Paul Ryan (R-WI) expected to succeed Rep. John Boehner (R-OH) as Speaker of the House, some Republican lawmakers are eyeing the opening Rep. Ryan would leave behind at the helm of the House Committee on Ways and Means. Several congressmen are expected … Continue Reading

21st Century Cures Act on House Floor; CMS Proposes Modification to Two Midnight Rule, Publishes End-Stage Renal Disease PPS Proposed Rule; Supreme Court Upholds ACA Subsidies

Legislative Activity House to Consider 21st Century Cures Act Majority Leader Kevin McCarthy (R-CA) has announced that the House of Representatives will consider H.R. 6, the 21st Century Cures Act, this week. The House Committee on Rules will meet to consider the rules for the debate on Wednesday, July 8. Amendments to the legislation are … Continue Reading

21st Century Cures Act Advances to Committee Markup; HHS Issues Guidance on Preventive Services; CMS Urges Physicians to Prepare for ICD-10

Legislative Activity Committee on Energy and Commerce to Mark Up 21st Century Cures Act On Tuesday, May 19, the House Committee on Energy and Commerce will begin its markup of the 21st Century Cures Act, to be continued on Wednesday, May 20. The legislation is the product of the bipartisan 21st Century Cures Initiative that … Continue Reading

Capitol Hill Looks Towards Health Care Innovation

Legislative Activity House and Senate Consider Medical Modernization Capitol Hill focuses on the future of health care this week. On Tuesday, the Senate Committee on Health, Education, Labor, and Pensions (HELP) will conduct a discussion on medical advancement and improvement with a hearing titled “Continuing America’s Leadership: The Future of Medical Innovation for Patients.” Dr. … Continue Reading

Senate Takes Shot At Vaccine-Preventable Diseases; Health Cybersecurity Examined; GAO Reports On ICD-10

Legislative Activity Senate Committee Takes Shot At Vaccine-Preventable Diseases This week, as the country faces a well-publicized outbreak of measles, the Senate Committee on Health, Education, Labor, and Pensions (HELP) will hold a hearing to discuss the reemergence of vaccine-preventable diseases. The media has publicized the measles outbreak after visitors and workers in California contracted … Continue Reading
LexBlog